Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Short-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
An examination of short-term operating activity ratios reveals several noteworthy trends over the observed period. Generally, the period between March 2022 and December 2025 demonstrates fluctuations in efficiency metrics, with some indicators suggesting a potential lengthening of operational cycles in the latter half of the analyzed timeframe.
- Inventory Management
- Inventory turnover exhibited a generally declining trend, moving from a high of 3.36 in March 2022 to a low of 2.62 in June 2023, before partially recovering to 2.98 by December 2025. This suggests a slower rate of inventory liquidation over time. Correspondingly, the average inventory processing period increased from 109 days in March 2022 to 139 days in June 2023, before decreasing to 123 days in December 2025. This indicates that, on average, inventory is held for a longer duration.
- Receivables Management
- Receivables turnover showed initial strength, peaking at 7.03 in September 2022, but then experienced a consistent decline to 5.59 in December 2025. This indicates a slowing in the rate at which receivables are collected. The average receivable collection period increased from 59 days in March 2022 to 67 days in June 2025, before decreasing slightly to 65 days in December 2025, suggesting a lengthening of the time required to collect payments from customers.
- Payables Management
- Payables turnover demonstrated some variability, with a peak of 4.67 in September 2022. It generally remained within a range of 4.02 to 4.56 throughout the period. The average payables payment period decreased from 91 days in March 2022 to 78 days in September 2022, then fluctuated between 80 and 87 days before settling at 80 days in December 2025. This suggests a relatively stable payment pattern to suppliers.
- Overall Operating Cycle & Cash Conversion
- The operating cycle generally increased from 168 days in March 2022 to 195 days in June 2025, before decreasing to 188 days in December 2025. This lengthening indicates a greater time span between the initial investment in inventory and the receipt of cash from sales. The cash conversion cycle followed a similar pattern, increasing from 77 days in March 2022 to 110 days in June 2025, and then decreasing to 108 days in December 2025. This suggests a growing need for working capital to fund operations, followed by a slight improvement in cash flow efficiency towards the end of the period.
- Working Capital Turnover
- Working capital turnover fluctuated throughout the period, starting at 4.13 in March 2022 and reaching a high of 4.83 in March 2024, before decreasing to 4.67 in December 2025. This indicates varying levels of efficiency in utilizing working capital to generate sales. The initial increase suggests improved efficiency, while the subsequent decline may indicate a need to reassess working capital management strategies.
In summary, the observed trends suggest a potential slowdown in operational efficiency, particularly concerning inventory and receivables management. While payables management remained relatively stable, the lengthening of the operating and cash conversion cycles warrants further investigation to identify potential areas for improvement in working capital management.
Turnover Ratios
Average No. Days
Inventory Turnover
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Cost of products sold, excluding amortization of intangible assets | |||||||||||||||||||||
| Inventories | |||||||||||||||||||||
| Short-term Activity Ratio | |||||||||||||||||||||
| Inventory turnover1 | |||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||
| Inventory Turnover, Competitors2 | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Inventory turnover
= (Cost of products sold, excluding amortization of intangible assetsQ4 2025
+ Cost of products sold, excluding amortization of intangible assetsQ3 2025
+ Cost of products sold, excluding amortization of intangible assetsQ2 2025
+ Cost of products sold, excluding amortization of intangible assetsQ1 2025)
÷ Inventories
= ( + + + )
÷ =
2 Click competitor name to see calculations.
Inventory turnover exhibited a generally declining trend over the observed period, with some fluctuations. Initially, the ratio demonstrated relative stability before experiencing a more pronounced decrease, followed by a partial recovery towards the end of the period.
- Initial Period (Mar 31, 2022 – Dec 31, 2022)
- The inventory turnover ratio began at 3.36 and decreased to 3.10 over this timeframe. While not a dramatic decline, this suggests a slight slowing in the rate at which inventory was sold and replenished during this period. Cost of products sold remained relatively consistent, while inventories increased slightly, contributing to the decrease in turnover.
- Subsequent Decline (Mar 31, 2023 – Jun 30, 2023)
- A more significant decrease in inventory turnover was observed, falling from 2.77 to a low of 2.62. This coincided with increases in both cost of products sold and inventory levels. This suggests a potential build-up of inventory relative to sales during this six-month period.
- Partial Recovery (Sep 30, 2023 – Dec 31, 2024)
- The ratio experienced a modest recovery, increasing from 2.71 to 3.02. This improvement appears to be driven by a combination of increased cost of products sold and a decrease in inventory levels, particularly evident between Sep 30, 2023 and Dec 31, 2024. However, the ratio did not return to the levels observed in the initial period.
- Recent Trend (Mar 31, 2025 – Dec 31, 2025)
- The most recent data indicates a continued, albeit slower, improvement in inventory turnover, rising from 2.82 to 2.98. Cost of products sold increased, while inventories decreased, contributing to this positive trend. This suggests a more efficient management of inventory in the latter part of the observed period.
- Overall Observations
- The fluctuations in inventory turnover may be attributable to various factors, including changes in demand, production levels, and supply chain dynamics. The initial decline followed by a partial recovery suggests potential adjustments in inventory management strategies. The recent upward trend is encouraging, but continued monitoring is warranted to assess its sustainability.
Receivables Turnover
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Net sales | |||||||||||||||||||||
| Trade receivables, less allowances | |||||||||||||||||||||
| Short-term Activity Ratio | |||||||||||||||||||||
| Receivables turnover1 | |||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||
| Receivables Turnover, Competitors2 | |||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Receivables turnover
= (Net salesQ4 2025
+ Net salesQ3 2025
+ Net salesQ2 2025
+ Net salesQ1 2025)
÷ Trade receivables, less allowances
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The receivables turnover ratio exhibits a fluctuating pattern over the observed period, spanning from March 31, 2022, to December 31, 2025. Initially, the ratio demonstrates relative stability with a slight increase, followed by a period of decline and subsequent volatility.
- Initial Period (Mar 31, 2022 – Jun 30, 2022)
- The receivables turnover ratio begins at 6.20 and increases to 6.33. This suggests a marginally improved efficiency in collecting receivables during this timeframe, indicating a slightly faster conversion of credit sales into cash.
- Peak and Subsequent Decline (Sep 30, 2022 – Jun 30, 2023)
- The ratio peaks at 7.03 in September 2022, before experiencing a consistent decline to 6.52 by June 2023. This decrease suggests a lengthening of the collection period, potentially due to changes in credit policies, customer payment behavior, or a shift in the sales mix towards customers with longer payment terms.
- Volatility and Further Decline (Sep 30, 2023 – Mar 31, 2025)
- From September 2023 through March 2025, the ratio demonstrates increased volatility, fluctuating between 6.15 and 5.78. A continued downward trend is evident, reaching a low of 5.41 in June 2025. This sustained decline indicates a progressively slower rate of receivables collection, potentially signaling emerging issues with credit management or increased credit risk.
- Recent Recovery (Jun 30, 2025 – Dec 31, 2025)
- The ratio shows a modest recovery in the final two quarters, increasing from 5.41 to 5.59. While this represents an improvement, the ratio remains below the levels observed earlier in the period, suggesting that collection efficiency has not fully recovered.
Overall, the trend indicates a weakening in receivables collection efficiency over the analyzed period. While fluctuations occur, the general direction points towards a longer collection cycle, which could tie up working capital and potentially increase the risk of bad debts. Further investigation into the underlying causes of this trend is warranted.
Payables Turnover
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Cost of products sold, excluding amortization of intangible assets | |||||||||||||||||||||
| Trade accounts payable | |||||||||||||||||||||
| Short-term Activity Ratio | |||||||||||||||||||||
| Payables turnover1 | |||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||
| Payables Turnover, Competitors2 | |||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Payables turnover
= (Cost of products sold, excluding amortization of intangible assetsQ4 2025
+ Cost of products sold, excluding amortization of intangible assetsQ3 2025
+ Cost of products sold, excluding amortization of intangible assetsQ2 2025
+ Cost of products sold, excluding amortization of intangible assetsQ1 2025)
÷ Trade accounts payable
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The payables turnover ratio exhibits a generally stable pattern over the observed period, with fluctuations occurring throughout the quarters. An initial increase is noted from March 2022 to June 2022, followed by a further increase through September 2022, before declining slightly in December 2022. This pattern of fluctuation continues into 2023 and 2024, with no consistently strong upward or downward trend dominating the entire timeframe.
- Overall Trend
- The payables turnover ratio generally remains within a narrow band, fluctuating between approximately 4.02 and 4.69. This suggests a consistent, though not dramatically changing, efficiency in managing payments to suppliers. There isn't a clear indication of a significant lengthening or shortening of the payment cycle over the period.
- Short-Term Fluctuations
- A peak in the ratio is observed in September 2022 at 4.67, indicating a relatively faster turnover of payables during that quarter. Conversely, the lowest ratio is recorded in March 2022 at 4.02, suggesting a slower turnover. Similar peaks and troughs are visible in subsequent periods, though the magnitude of these fluctuations remains relatively contained.
- Recent Performance (2024-2025)
- From March 2024 through December 2025, the ratio demonstrates continued variability, remaining largely within the 4.40 to 4.69 range. The ratio in September 2025 (4.69) represents one of the higher values observed throughout the entire period, while the ratio in June 2025 (4.40) is near the lower end of the range. This suggests that recent performance is consistent with the historical pattern of moderate fluctuations.
The observed fluctuations in the payables turnover ratio may be influenced by factors such as seasonal purchasing patterns, supplier payment terms, and the timing of invoice processing. Further investigation into these underlying factors would be necessary to provide a more comprehensive understanding of the observed trends.
Working Capital Turnover
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Current assets | |||||||||||||||||||||
| Less: Current liabilities | |||||||||||||||||||||
| Working capital | |||||||||||||||||||||
| Net sales | |||||||||||||||||||||
| Short-term Activity Ratio | |||||||||||||||||||||
| Working capital turnover1 | |||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||
| Working Capital Turnover, Competitors2 | |||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Working capital turnover
= (Net salesQ4 2025
+ Net salesQ3 2025
+ Net salesQ2 2025
+ Net salesQ1 2025)
÷ Working capital
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The working capital turnover ratio exhibits fluctuations over the observed period, generally indicating a moderate level of efficiency in utilizing working capital to generate sales. An initial decline is followed by periods of relative stability and eventual increase.
- Overall Trend
- The ratio demonstrates a generally stable pattern between 3.63 and 4.83 over the analyzed timeframe. While there are quarterly variations, a clear, sustained upward or downward trend is not immediately apparent. The most recent periods show an increase, peaking at 4.67 in December 2025.
- Initial Decline and Recovery (2022-2023)
- The ratio decreased from 4.13 in March 2022 to 3.63 in June 2022, before recovering to 4.21 by March 2023. This initial decline could suggest a temporary slowdown in the efficiency of working capital utilization, potentially due to increased inventory levels or slower collection of receivables. The subsequent recovery indicates a return to more typical operational efficiency.
- Mid-Period Stability (2023-2024)
- From June 2023 through March 2024, the ratio remained relatively stable, fluctuating between 3.91 and 4.39. This suggests a consistent approach to managing working capital and a predictable relationship between working capital and net sales during this period.
- Recent Increase (2024-2025)
- The ratio experienced an upward trend in the latter part of the period, increasing from 4.35 in June 2024 to 4.67 in December 2025. This improvement suggests enhanced efficiency in managing working capital, potentially through improved inventory management, faster receivables collection, or optimized payment terms with suppliers. The increase is notable and warrants further investigation to understand the underlying drivers.
- Relationship to Net Sales
- The fluctuations in the working capital turnover ratio generally correspond with changes in net sales. Periods of lower turnover often coincide with lower sales figures, and vice versa. However, the relationship is not perfectly linear, indicating that factors beyond sales volume also influence working capital efficiency.
In conclusion, the working capital turnover ratio demonstrates a generally healthy and stable performance with a recent positive trend. Continued monitoring is recommended to assess the sustainability of the recent improvements and to identify any potential areas for further optimization.
Average Inventory Processing Period
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||
| Inventory turnover | |||||||||||||||||||||
| Short-term Activity Ratio (no. days) | |||||||||||||||||||||
| Average inventory processing period1 | |||||||||||||||||||||
| Benchmarks (no. days) | |||||||||||||||||||||
| Average Inventory Processing Period, Competitors2 | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ =
2 Click competitor name to see calculations.
The average inventory processing period exhibited a generally increasing trend over the observed timeframe, with some fluctuations. Initially, the period fluctuated around 109-113 days before increasing to a peak in the second quarter of 2023. Subsequently, the period decreased, but remained elevated compared to the earlier periods.
- Overall Trend
- From March 31, 2022, to December 31, 2025, the average inventory processing period generally increased. The period began at 109 days and concluded at 123 days. While there were quarterly variations, the overall direction indicates a lengthening of the time required to convert inventory into sales.
- Initial Period (Mar 31, 2022 – Dec 31, 2022)
- The average inventory processing period remained relatively stable during this period, fluctuating between 108 and 118 days. This suggests consistent inventory management practices during this timeframe.
- Peak and Subsequent Decline (Mar 31, 2023 – Jun 30, 2023)
- A notable increase in the average inventory processing period was observed in the first two quarters of 2023, reaching 132 and 139 days respectively. This represents the highest points in the observed period. Following this peak, the period began to decline, reaching 127 days by September 30, 2025.
- Recent Period (Sep 30, 2023 – Dec 31, 2025)
- The average inventory processing period demonstrated a slight downward trend in the most recent quarters, decreasing from 135 days to 123 days. This suggests potential improvements in inventory management or increased sales velocity towards the end of the observation period.
- Correlation with Inventory Turnover
- An inverse relationship exists between the average inventory processing period and inventory turnover. As the inventory processing period increased, the inventory turnover ratio generally decreased, and vice versa. This is expected, as a longer processing period implies slower inventory movement and fewer turnovers within the same timeframe.
Average Receivable Collection Period
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||
| Receivables turnover | |||||||||||||||||||||
| Short-term Activity Ratio (no. days) | |||||||||||||||||||||
| Average receivable collection period1 | |||||||||||||||||||||
| Benchmarks (no. days) | |||||||||||||||||||||
| Average Receivable Collection Period, Competitors2 | |||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ =
2 Click competitor name to see calculations.
The average receivable collection period exhibited a generally increasing trend over the observed timeframe, though with some fluctuations. Initially, the period demonstrated relative stability before gradually lengthening in later periods.
- Overall Trend
- From March 31, 2022, through December 31, 2022, the average collection period remained relatively consistent, fluctuating between 52 and 59 days. A gradual increase began in the first quarter of 2023, continuing through the second quarter of 2025. The period rose from 53 days in March 2023 to 68 days in September 2025, before decreasing slightly to 65 days by the end of 2025.
- Short-Term Fluctuations
- A slight decrease in the average collection period was observed between March 31, 2022 (59 days) and June 30, 2022 (58 days). Similarly, a minor reduction occurred between September 30, 2022 (52 days) and December 31, 2022 (52 days). However, these decreases were not sustained.
- Recent Performance
- The most recent periods show a potential stabilization, or slight reversal, of the increasing trend. The collection period peaked at 68 days in September 2025, then decreased to 65 days in December 2025. This suggests a possible improvement in collection efficiency towards the end of the analyzed period, although further monitoring is needed to confirm this trend.
- Longer-Term Changes
- Comparing the beginning and end of the period, the average collection period increased by approximately 6 days, moving from 59 days in March 2022 to 65 days in December 2025. This indicates a lengthening of the time required to collect receivables, which could be attributable to changes in credit policies, customer payment behavior, or other factors impacting the cash conversion cycle.
The observed increases in the average collection period warrant further investigation to determine the underlying causes and potential implications for liquidity and working capital management.
Operating Cycle
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||
| Average inventory processing period | |||||||||||||||||||||
| Average receivable collection period | |||||||||||||||||||||
| Short-term Activity Ratio | |||||||||||||||||||||
| Operating cycle1 | |||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||
| Operating Cycle, Competitors2 | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= + =
2 Click competitor name to see calculations.
The operating cycle exhibited a generally increasing trend over the observed period, with some fluctuations. Analysis of the component ratios reveals the drivers behind this overall pattern. The average inventory processing period and average receivable collection period both contributed to the lengthening of the operating cycle.
- Average Inventory Processing Period
- The average inventory processing period demonstrated an upward trend from 109 days in March 2022 to a peak of 139 days in June 2022. It subsequently decreased to 123 days by December 2025, but remained consistently above the initial value recorded in March 2022. A period of relative stability was observed between March 2023 and September 2024, fluctuating between 132 and 136 days. The most recent quarters show a slight decrease, suggesting potential improvements in inventory management.
- Average Receivable Collection Period
- The average receivable collection period showed a consistent increase throughout the majority of the period. Starting at 59 days in March 2022, it rose to 68 days by September 2025. This indicates a lengthening of the time required to collect payments from customers. A slight decrease to 65 days was observed in December 2025, but the overall trend remains upward. The period remained relatively stable between March 2022 and September 2022, fluctuating between 52 and 59 days.
- Operating Cycle
- The operating cycle increased from 168 days in March 2022 to a high of 201 days in June 2025. This increase reflects the combined effect of the lengthening inventory processing and receivable collection periods. A slight decrease to 188 days was observed in December 2025. The operating cycle generally remained between 160 and 171 days during the earlier portion of the period (March 2022 to September 2022), before experiencing more substantial increases. The most recent quarter shows a decrease, potentially indicating improved efficiency.
The consistent increase in both the average inventory processing period and the average receivable collection period suggests potential inefficiencies in either inventory management, credit policies, or collection efforts. The lengthening operating cycle implies that the company is taking longer to convert its investments in inventory and accounts receivable into cash. Monitoring these trends closely is recommended to identify the root causes and implement appropriate corrective actions.
Average Payables Payment Period
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||
| Payables turnover | |||||||||||||||||||||
| Short-term Activity Ratio (no. days) | |||||||||||||||||||||
| Average payables payment period1 | |||||||||||||||||||||
| Benchmarks (no. days) | |||||||||||||||||||||
| Average Payables Payment Period, Competitors2 | |||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ =
2 Click competitor name to see calculations.
The average payables payment period exhibited fluctuations over the observed period, generally remaining within a relatively narrow range. An initial decrease was followed by periods of stability and slight increases, ultimately concluding with a period resembling the initial values.
- Overall Trend
- The average payables payment period began at 91 days in March 2022, decreased to a low of 78 days by September 2022, and then generally fluctuated between 80 and 88 days through December 2024. The period concluded at 80 days in December 2025, mirroring the value observed in September 2022 and remaining close to the latter half of the observed period.
- Short-Term Fluctuations
- A noticeable decline occurred between March 2022 and September 2022, indicating a shortening of the time taken to settle obligations to suppliers. A subsequent increase was observed between September 2022 and December 2022. The period from March 2023 to September 2024 showed minimal variation, remaining consistently around 82-85 days. A slight decrease was noted in September 2025, followed by a return to 80 days in December 2025.
- Recent Performance
- The final four quarters (March 2024 – December 2025) demonstrate a stable payment period, fluctuating between 80 and 83 days. This suggests consistent supplier payment practices during this timeframe. The concluding value of 80 days in December 2025 is consistent with the lower end of the range observed throughout the period.
The observed fluctuations, while present, do not indicate any dramatic shifts in the company’s approach to managing its payables. The period remained largely contained, suggesting a consistent, albeit dynamic, relationship with its suppliers.
Cash Conversion Cycle
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||
| Average inventory processing period | |||||||||||||||||||||
| Average receivable collection period | |||||||||||||||||||||
| Average payables payment period | |||||||||||||||||||||
| Short-term Activity Ratio | |||||||||||||||||||||
| Cash conversion cycle1 | |||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||
| Cash Conversion Cycle, Competitors2 | |||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= + – =
2 Click competitor name to see calculations.
The short-term operating activity of the company, as measured by its cash conversion cycle and component ratios, exhibits notable fluctuations over the observed period. An initial period of relative stability is followed by a period of increasing inefficiency, then a partial recovery. The analysis below details these trends.
- Average Inventory Processing Period
- The average number of days to process inventory generally increased from 109 days in March 2022 to a peak of 139 days in June 2023. Following this peak, the period decreased, reaching 123 days by December 2025. While fluctuations exist, the period consistently remained above the initial value observed in March 2022, suggesting a lengthening of the inventory cycle overall. The most recent quarter shows a slight decrease, potentially indicating improved inventory management.
- Average Receivable Collection Period
- The average number of days to collect receivables demonstrated a gradual upward trend. Starting at 59 days in March 2022, the collection period increased to 68 days in September 2025, with some quarterly variations. The period remained relatively stable between 52 and 60 days throughout 2022 and early 2023, but then consistently increased. The December 2025 value of 65 days represents a slight decrease from the peak, but remains elevated compared to the earlier period.
- Average Payables Payment Period
- The average number of days to pay suppliers exhibited more moderate fluctuations. The period began at 91 days in March 2022, decreased to a low of 78 days in September 2022, and then generally stabilized between 80 and 91 days. There is no clear, sustained trend of increasing or decreasing payment terms over the period. The period ended at 80 days in December 2025, similar to the values observed in late 2022 and early 2023.
- Cash Conversion Cycle
- The cash conversion cycle increased significantly from 77 days in March 2022 to a peak of 118 days in June 2025. This increase was driven primarily by the lengthening inventory processing and receivable collection periods. Following the peak, the cycle decreased to 108 days by December 2025, suggesting some improvement in working capital management. However, the cycle remains substantially longer than the initial value, indicating a less efficient use of working capital compared to the beginning of the observed period. The cycle experienced a relatively stable period between March 2022 and December 2022, before the upward trend began.
In summary, the company experienced a deterioration in its cash conversion cycle, primarily due to increases in the time required to process inventory and collect receivables. While there is some evidence of improvement in the most recent quarters, the cycle remains elevated compared to earlier periods, suggesting ongoing challenges in managing working capital effectively.